Two students from the Drug Design department selected for this years 65th Lindau Nobel Laureate Meeting
Every year few students are selected from different countries to closely interact over several days with Nobel Laureates from their disciplines at the yearly "Lindau Nobel Laureate Meeting" in Germany. Last year only nine Dutch students could attend. This year two students from the Drug Design group at RUG were chosen: PhD student and holder of an Erasmus Mundus SWAGATA scholarship Ajay Chandgude and postdoctoral student Constantinos Neochoritis. "I am blown away about being chosen in a such high class, in all respects meeting. This happens once in a lifetime and I feel deeply honoured, excited and sincerely look forward to be part of it. Interacting with the 70 Nobel Laureate and world’s top 650 young researchers in a week; it’s like a dream for me. This is a unique opportunity to experience science from a different perspective, to widen my horizons and get lifetime inspiration about how to do successful research with a great social impact", says Ajay Chandgude. Congratulation to Constantinos and Ajay!
New grants per Dec. 1, 2014
Qatar grant: QNRF NPRP No.:NPRP6-065-3-012: Protein Engineering of Glucarpidase to Improve Cancer Therapy Strategies: New synthesis of novel bioactive class of natural products
STW 13547: “Design, synthesis and validation of potent and isoenzyme specific arginase Inhibitors for treatment of asthma”. 2015-2019.
Symphony grant 2014/12/W/NZ1/00457: Transient protein states in designing small-molecule inhibitors of protein-protein interactions. 6 496 600 PLN, 2014-1018. The National Science Centre (Poland) (https://www.ncn.gov.pl/?language=en )  has awarded the grant “Symphony 2” to the team of four scientists from Poland (3) and Netherlands (prof. Dömling) for the total of 1.5 million Euros (6.5mln PLN) for 2014-2018.
Prof Alexander Dömling is awarded the Smoluchowski visiting professorship at the Jagiellonian University, Krakow, Poland
Prof Alexander Dömling, head of the Department for Drug Design at GRIP is awarded the Smoluchowski visiting professorship at the Faculty of Chemistry of the Jagiellonian University, Krakow, Poland. During his stay in December 2013 in Krakow he will teach a short course on multicomponent reaction chemistry and a practical course on computational structure-based drug design. The prestigious Smoluchowski visiting professorship is named after the Polish scientist Marian Smoluchowski who contributed fundamental work amongst others in the area of the blue color of the sky as a consequence of light dispersion on fluctuations in the atmosphere. The Jagiellonian University was established in 1364 and is one of the oldest universities in the world. It was just announced as the elite Universities of Poland.
The Drug Design Group participates in a € 196 million pan-european drug discovery platform. Click here to read the press release. (Febr. 2013)
Book "Protein-protein interactions in drug discovery"
Prof Dömling, the editor of "Protein-protein interactions in drug discovery" is happy to announce that the book was published (Jan. 2013). Protein-protein interactions are an upcoming very large group of targets for pharmaceutical intervention which have been largely neglected by pharma companies in the past due to the complexity of discovering suitable antagonists. The book combines chapters from industrial and academic experts in the field. Several clinical compounds are highlighted and their discovery process discussed. Prof Dömling's contribution in the field is the discovery of novel potent and selective classes of anticancer p53-mdm2 and mdm4 antagonist using the in house developed designer software ANCHOR.QUERY (http://anchorquery.ccbb.pitt.edu/).
Click here for more information about this book.
|Laatst gewijzigd:||04 maart 2015 08:22|